Beit Jala Pharmaceutical Past Earnings Performance
Past criteria checks 5/6
Beit Jala Pharmaceutical has been growing earnings at an average annual rate of 22.1%, while the Pharmaceuticals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 4% per year. Beit Jala Pharmaceutical's return on equity is 13.9%, and it has net margins of 21.4%.
Key information
22.10%
Earnings growth rate
22.10%
EPS growth rate
Pharmaceuticals Industry Growth
12.39%
Revenue growth rate
3.97%
Return on equity
13.88%
Net Margin
21.39%
Last Earnings Update
31 Dec 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Beit Jala Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
PLSE:BJP Revenue, expenses and earnings (JOD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
13
3
2
0
30 Sep 25
12
3
1
0
30 Jun 25
12
3
1
0
31 Mar 25
11
2
1
0
31 Dec 24
10
2
1
0
30 Sep 24
9
1
1
0
30 Jun 24
9
1
1
0
31 Mar 24
9
2
1
0
31 Dec 23
10
2
1
0
30 Sep 23
10
2
1
0
30 Jun 23
10
2
1
0
31 Mar 23
11
2
2
0
31 Dec 22
11
2
2
0
30 Sep 22
11
2
2
0
30 Jun 22
11
2
2
0
31 Mar 22
10
1
2
0
31 Dec 21
10
1
2
0
30 Sep 21
9
1
2
0
30 Jun 21
9
1
2
0
31 Mar 21
9
1
2
0
31 Dec 20
9
1
2
0
30 Sep 20
9
1
2
0
30 Jun 20
9
1
2
0
31 Mar 20
9
2
2
0
31 Dec 19
9
1
1
0
30 Sep 19
8
1
1
0
30 Jun 19
8
1
1
0
31 Mar 19
7
1
1
0
31 Dec 18
7
1
1
0
30 Sep 18
8
1
1
0
30 Jun 18
8
1
1
0
31 Mar 18
8
2
1
0
31 Dec 17
8
2
2
0
30 Sep 17
8
2
1
0
30 Jun 17
8
2
1
0
31 Mar 17
8
2
1
0
31 Dec 16
8
2
1
0
30 Sep 16
8
2
1
0
30 Jun 16
8
2
1
0
31 Mar 16
8
1
1
0
31 Dec 15
8
2
1
0
30 Sep 15
7
1
1
0
30 Jun 15
6
1
1
0
Quality Earnings: BJP has high quality earnings.
Growing Profit Margin: BJP's current net profit margins (21.4%) are higher than last year (18.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BJP's earnings have grown significantly by 22.1% per year over the past 5 years.
Accelerating Growth: BJP's earnings growth over the past year (55.7%) exceeds its 5-year average (22.1% per year).
Earnings vs Industry: BJP earnings growth over the past year (55.7%) exceeded the Pharmaceuticals industry 8.5%.
Return on Equity
High ROE: BJP's Return on Equity (13.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/04/12 18:51
End of Day Share Price
2026/01/13 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beit Jala Pharmaceutical Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.